CTVA
Corteva, Inc.
NYSEUSDEQUITY
DELAYED
Last price
81.82
▲ 2.36 (2.97%)
MARKET · —
Price
Open
79.09
Prev close
79.46
Day high
82.15
Day low
79.45
Volume
4.65M
Market cap
—
P/E (TTM)
—
52W range
60.54 – 90.97
Trailing performance
Returnvs SPY
1W
+6.66%
+8.0%
1M
-7.87%
-11.6%
3M
+3.48%
+0.4%
6M
+7.18%
-3.9%
YTD
+22.02%
+9.7%
1Y
+12.10%
-7.9%
3Y
+63.55%
-10.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
77.44
+5.65% from price
SMA 20
79.81
+2.48% from price
SMA 50
81.86
-0.09% from price
SMA 100
81.25
+0.70% from price
SMA 200
76.34
+7.14% from price
EMA 12
78.85
+3.77% from price
EMA 26
80.14
+2.10% from price
EMA 50
80.88
+1.17% from price
RSI (14)
54.8
Neutral
MACD (12,26,9)
-1.29
Hist 0.37
ATR (14)
2.02
2.47% of price
Realised vol 30D
44.0%
Annualised
Bollinger upper
89.59
20, 2σ
Bollinger lower
70.04
20, 2σ
50 / 200 cross
Golden
81.86 vs 76.34
Trend bias
Above 200
+7.14%
Risk profile
Beta vs SPY
0.13
Less volatile than market
Correlation to SPY
0.06
Largely independent
Realised vol 30D
44.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-18.7%
Peak to trough
Max drawdown 5Y
-35.3%
Peak to trough
ATR 14
2.02
2.47% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Corteva Announces Early Tender Results and Extension of Expiration Date in Private Exchange Offers and Consent Solicitations for EIDP's 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 and 4.800% Senior Notes Due 2033
PR Newswire · 2d ago
Corteva's Stock Now Has Better Setup Into Upcoming Investor Days, Spin off, Following Earnings, UBS Says
MT Newswires · 3d ago
Corteva (CTVA) Stock May Be 32% Undervalued After Debt Exchange Offers
Simply Wall St. · 4d ago
UBS Adjusts Price Target on Corteva to $85 From $89, Maintains Neutral Rating
MT Newswires · 4d ago
Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Quarterly Update Report
Exec Edge · 4d ago
Can Strategic Investments Boost Mission Produce's Returns?
Zacks · 5d ago
Microbial Inoculants & N-Fixing Microbes Market Report 2026–2035: Evaluating $6.7 Billion Forecast, Liquid Formulations, and Strategies of Novonesis, BASF, Corteva, and Bioceres
GlobeNewswire · 8d ago
DOLE vs. CTVA: Which Stock Is the Better Value Option?
Zacks · 9d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.